Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Intermediates Market Size(US$)
CAGR 2024-2030
6.3%
Market Size,2030
USD 280,690
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 194,550 million
Market Forecast in 2030(Value)
US$ 280,690 million
CAGR
6.3%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
The global Pharmaceutical Intermediates market is projected to grow from US$ 194550 million in 2024 to US$ 280690 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
Report Covers:
This report presents an overview of global market for Pharmaceutical Intermediates, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmaceutical Intermediates, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Intermediates, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical Intermediates sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical Intermediates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical Intermediates sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- GMP
- Non-GMP
Segment by Application
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pharmaceutical Intermediates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pharmaceutical Intermediates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Intermediates sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market by Type
1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 GMP
1.2.3 Non-GMP
1.3 Market by Application
1.3.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Antibiotics
1.3.3 Antipyretic Analgesics
1.3.4 Vitamins
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Intermediates Sales Estimates and Forecasts 2019-2030
2.2 Global Pharmaceutical Intermediates Revenue by Region
2.2.1 Global Pharmaceutical Intermediates Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pharmaceutical Intermediates Revenue by Region (2019-2024)
2.2.3 Global Pharmaceutical Intermediates Revenue by Region (2025-2030)
2.2.4 Global Pharmaceutical Intermediates Revenue Market Share by Region (2019-2030)
2.3 Global Pharmaceutical Intermediates Sales Estimates and Forecasts 2019-2030
2.4 Global Pharmaceutical Intermediates Sales by Region
2.4.1 Global Pharmaceutical Intermediates Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pharmaceutical Intermediates Sales by Region (2019-2024)
2.4.3 Global Pharmaceutical Intermediates Sales by Region (2025-2030)
2.4.4 Global Pharmaceutical Intermediates Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pharmaceutical Intermediates Sales by Manufacturers
3.1.1 Global Pharmaceutical Intermediates Sales by Manufacturers (2019-2024)
3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharmaceutical Intermediates in 2023
3.2 Global Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Global Pharmaceutical Intermediates Revenue by Manufacturers (2019-2024)
3.2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2023
3.3 Global Key Players of Pharmaceutical Intermediates, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pharmaceutical Intermediates Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pharmaceutical Intermediates, Product Offered and Application
3.8 Global Key Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharmaceutical Intermediates Sales by Type
4.1.1 Global Pharmaceutical Intermediates Historical Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Intermediates Forecasted Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Intermediates Revenue by Type
4.2.1 Global Pharmaceutical Intermediates Historical Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Intermediates Price by Type
4.3.1 Global Pharmaceutical Intermediates Price by Type (2019-2024)
4.3.2 Global Pharmaceutical Intermediates Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pharmaceutical Intermediates Sales by Application
5.1.1 Global Pharmaceutical Intermediates Historical Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Intermediates Forecasted Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Intermediates Revenue by Application
5.2.1 Global Pharmaceutical Intermediates Historical Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Intermediates Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Intermediates Price by Application
5.3.1 Global Pharmaceutical Intermediates Price by Application (2019-2024)
5.3.2 Global Pharmaceutical Intermediates Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pharmaceutical Intermediates Market Size by Type
6.1.1 US & Canada Pharmaceutical Intermediates Sales by Type (2019-2030)
6.1.2 US & Canada Pharmaceutical Intermediates Revenue by Type (2019-2030)
6.2 US & Canada Pharmaceutical Intermediates Market Size by Application
6.2.1 US & Canada Pharmaceutical Intermediates Sales by Application (2019-2030)
6.2.2 US & Canada Pharmaceutical Intermediates Revenue by Application (2019-2030)
6.3 US & Canada Pharmaceutical Intermediates Market Size by Country
6.3.1 US & Canada Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pharmaceutical Intermediates Sales by Country (2019-2030)
6.3.3 US & Canada Pharmaceutical Intermediates Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pharmaceutical Intermediates Market Size by Type
7.1.1 Europe Pharmaceutical Intermediates Sales by Type (2019-2030)
7.1.2 Europe Pharmaceutical Intermediates Revenue by Type (2019-2030)
7.2 Europe Pharmaceutical Intermediates Market Size by Application
7.2.1 Europe Pharmaceutical Intermediates Sales by Application (2019-2030)
7.2.2 Europe Pharmaceutical Intermediates Revenue by Application (2019-2030)
7.3 Europe Pharmaceutical Intermediates Market Size by Country
7.3.1 Europe Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pharmaceutical Intermediates Sales by Country (2019-2030)
7.3.3 Europe Pharmaceutical Intermediates Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pharmaceutical Intermediates Market Size
8.1.1 China Pharmaceutical Intermediates Sales (2019-2030)
8.1.2 China Pharmaceutical Intermediates Revenue (2019-2030)
8.2 China Pharmaceutical Intermediates Market Size by Application
8.2.1 China Pharmaceutical Intermediates Sales by Application (2019-2030)
8.2.2 China Pharmaceutical Intermediates Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pharmaceutical Intermediates Market Size by Type
9.1.1 Asia Pharmaceutical Intermediates Sales by Type (2019-2030)
9.1.2 Asia Pharmaceutical Intermediates Revenue by Type (2019-2030)
9.2 Asia Pharmaceutical Intermediates Market Size by Application
9.2.1 Asia Pharmaceutical Intermediates Sales by Application (2019-2030)
9.2.2 Asia Pharmaceutical Intermediates Revenue by Application (2019-2030)
9.3 Asia Pharmaceutical Intermediates Sales by Region
9.3.1 Asia Pharmaceutical Intermediates Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pharmaceutical Intermediates Revenue by Region (2019-2030)
9.3.3 Asia Pharmaceutical Intermediates Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Market Size by Type
10.1.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Market Size by Application
10.2.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Country
10.3.1 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Overview
11.1.3 Lonza Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Lonza Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lonza Recent Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Overview
11.2.3 Catalent Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Catalent Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Catalent Recent Developments
11.3 Patheon
11.3.1 Patheon Company Information
11.3.2 Patheon Overview
11.3.3 Patheon Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Patheon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Patheon Recent Developments
11.4 Jubilant
11.4.1 Jubilant Company Information
11.4.2 Jubilant Overview
11.4.3 Jubilant Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Jubilant Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jubilant Recent Developments
11.5 Granules
11.5.1 Granules Company Information
11.5.2 Granules Overview
11.5.3 Granules Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Granules Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Granules Recent Developments
11.6 Ganesh
11.6.1 Ganesh Company Information
11.6.2 Ganesh Overview
11.6.3 Ganesh Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Ganesh Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ganesh Recent Developments
11.7 Chemcon
11.7.1 Chemcon Company Information
11.7.2 Chemcon Overview
11.7.3 Chemcon Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Chemcon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Chemcon Recent Developments
11.8 BASF
11.8.1 BASF Company Information
11.8.2 BASF Overview
11.8.3 BASF Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 BASF Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BASF Recent Developments
11.9 Porton
11.9.1 Porton Company Information
11.9.2 Porton Overview
11.9.3 Porton Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Porton Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Porton Recent Developments
11.10 Lianhetech
11.10.1 Lianhetech Company Information
11.10.2 Lianhetech Overview
11.10.3 Lianhetech Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Lianhetech Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lianhetech Recent Developments
11.11 ABA Chem
11.11.1 ABA Chem Company Information
11.11.2 ABA Chem Overview
11.11.3 ABA Chem Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 ABA Chem Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ABA Chem Recent Developments
11.12 Tianma
11.12.1 Tianma Company Information
11.12.2 Tianma Overview
11.12.3 Tianma Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Tianma Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tianma Recent Developments
11.13 Jiujiujiu
11.13.1 Jiujiujiu Company Information
11.13.2 Jiujiujiu Overview
11.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Jiujiujiu Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jiujiujiu Recent Developments
11.14 Alpha
11.14.1 Alpha Company Information
11.14.2 Alpha Overview
11.14.3 Alpha Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Alpha Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Alpha Recent Developments
11.15 Jiuzhou
11.15.1 Jiuzhou Company Information
11.15.2 Jiuzhou Overview
11.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Jiuzhou Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Jiuzhou Recent Developments
11.16 Yongtai
11.16.1 Yongtai Company Information
11.16.2 Yongtai Overview
11.16.3 Yongtai Pharmaceutical Intermediates Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Yongtai Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Yongtai Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharmaceutical Intermediates Industry Chain Analysis
12.2 Pharmaceutical Intermediates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharmaceutical Intermediates Production Mode & Process
12.4 Pharmaceutical Intermediates Sales and Marketing
12.4.1 Pharmaceutical Intermediates Sales Channels
12.4.2 Pharmaceutical Intermediates Distributors
12.5 Pharmaceutical Intermediates Customers
13 Market Dynamics
13.1 Pharmaceutical Intermediates Industry Trends
13.2 Pharmaceutical Intermediates Market Drivers
13.3 Pharmaceutical Intermediates Market Challenges
13.4 Pharmaceutical Intermediates Market Restraints
14 Key Findings in The Global Pharmaceutical Intermediates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of GMP
Table 3. Major Manufacturers of Non-GMP
Table 4. Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Pharmaceutical Intermediates Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Pharmaceutical Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Pharmaceutical Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Pharmaceutical Intermediates Revenue Market Share by Region (2019-2024)
Table 9. Global Pharmaceutical Intermediates Revenue Market Share by Region (2025-2030)
Table 10. Global Pharmaceutical Intermediates Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Pharmaceutical Intermediates Sales by Region (2019-2024) & (K MT)
Table 12. Global Pharmaceutical Intermediates Sales by Region (2025-2030) & (K MT)
Table 13. Global Pharmaceutical Intermediates Sales Market Share by Region (2019-2024)
Table 14. Global Pharmaceutical Intermediates Sales Market Share by Region (2025-2030)
Table 15. Global Pharmaceutical Intermediates Sales by Manufacturers (2019-2024) & (K MT)
Table 16. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2019-2024)
Table 17. Global Pharmaceutical Intermediates Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Pharmaceutical Intermediates, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Pharmaceutical Intermediates Price by Manufacturers 2019-2024 (USD/MT)
Table 21. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2023)
Table 23. Global Key Manufacturers of Pharmaceutical Intermediates, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pharmaceutical Intermediates, Product Offered and Application
Table 25. Global Key Manufacturers of Pharmaceutical Intermediates, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Intermediates Sales by Type (2019-2024) & (K MT)
Table 28. Global Pharmaceutical Intermediates Sales by Type (2025-2030) & (K MT)
Table 29. Global Pharmaceutical Intermediates Sales Share by Type (2019-2024)
Table 30. Global Pharmaceutical Intermediates Sales Share by Type (2025-2030)
Table 31. Global Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Pharmaceutical Intermediates Revenue Share by Type (2019-2024)
Table 34. Global Pharmaceutical Intermediates Revenue Share by Type (2025-2030)
Table 35. Pharmaceutical Intermediates Price by Type (2019-2024) & (USD/MT)
Table 36. Global Pharmaceutical Intermediates Price Forecast by Type (2025-2030) & (USD/MT)
Table 37. Global Pharmaceutical Intermediates Sales by Application (2019-2024) & (K MT)
Table 38. Global Pharmaceutical Intermediates Sales by Application (2025-2030) & (K MT)
Table 39. Global Pharmaceutical Intermediates Sales Share by Application (2019-2024)
Table 40. Global Pharmaceutical Intermediates Sales Share by Application (2025-2030)
Table 41. Global Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Pharmaceutical Intermediates Revenue Share by Application (2019-2024)
Table 44. Global Pharmaceutical Intermediates Revenue Share by Application (2025-2030)
Table 45. Pharmaceutical Intermediates Price by Application (2019-2024) & (USD/MT)
Table 46. Global Pharmaceutical Intermediates Price Forecast by Application (2025-2030) & (USD/MT)
Table 47. US & Canada Pharmaceutical Intermediates Sales by Type (2019-2024) & (K MT)
Table 48. US & Canada Pharmaceutical Intermediates Sales by Type (2025-2030) & (K MT)
Table 49. US & Canada Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Pharmaceutical Intermediates Sales by Application (2019-2024) & (K MT)
Table 52. US & Canada Pharmaceutical Intermediates Sales by Application (2025-2030) & (K MT)
Table 53. US & Canada Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Pharmaceutical Intermediates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Pharmaceutical Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Pharmaceutical Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Pharmaceutical Intermediates Sales by Country (2019-2024) & (K MT)
Table 59. US & Canada Pharmaceutical Intermediates Sales by Country (2025-2030) & (K MT)
Table 60. Europe Pharmaceutical Intermediates Sales by Type (2019-2024) & (K MT)
Table 61. Europe Pharmaceutical Intermediates Sales by Type (2025-2030) & (K MT)
Table 62. Europe Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Pharmaceutical Intermediates Sales by Application (2019-2024) & (K MT)
Table 65. Europe Pharmaceutical Intermediates Sales by Application (2025-2030) & (K MT)
Table 66. Europe Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Pharmaceutical Intermediates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Pharmaceutical Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Pharmaceutical Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Pharmaceutical Intermediates Sales by Country (2019-2024) & (K MT)
Table 72. Europe Pharmaceutical Intermediates Sales by Country (2025-2030) & (K MT)
Table 73. China Pharmaceutical Intermediates Sales by Type (2019-2024) & (K MT)
Table 74. China Pharmaceutical Intermediates Sales by Type (2025-2030) & (K MT)
Table 75. China Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Pharmaceutical Intermediates Sales by Application (2019-2024) & (K MT)
Table 78. China Pharmaceutical Intermediates Sales by Application (2025-2030) & (K MT)
Table 79. China Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Pharmaceutical Intermediates Sales by Type (2019-2024) & (K MT)
Table 82. Asia Pharmaceutical Intermediates Sales by Type (2025-2030) & (K MT)
Table 83. Asia Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Pharmaceutical Intermediates Sales by Application (2019-2024) & (K MT)
Table 86. Asia Pharmaceutical Intermediates Sales by Application (2025-2030) & (K MT)
Table 87. Asia Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Pharmaceutical Intermediates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Pharmaceutical Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Pharmaceutical Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Pharmaceutical Intermediates Sales by Region (2019-2024) & (K MT)
Table 93. Asia Pharmaceutical Intermediates Sales by Region (2025-2030) & (K MT)
Table 94. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Type (2019-2024) & (K MT)
Table 95. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Type (2025-2030) & (K MT)
Table 96. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Application (2019-2024) & (K MT)
Table 99. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Application (2025-2030) & (K MT)
Table 100. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Country (2019-2024) & (K MT)
Table 106. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales by Country (2025-2030) & (K MT)
Table 107. Lonza Company Information
Table 108. Lonza Description and Major Businesses
Table 109. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Lonza Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Lonza Recent Developments
Table 112. Catalent Company Information
Table 113. Catalent Description and Major Businesses
Table 114. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Catalent Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Catalent Recent Developments
Table 117. Patheon Company Information
Table 118. Patheon Description and Major Businesses
Table 119. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Patheon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Patheon Recent Developments
Table 122. Jubilant Company Information
Table 123. Jubilant Description and Major Businesses
Table 124. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. Jubilant Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Jubilant Recent Developments
Table 127. Granules Company Information
Table 128. Granules Description and Major Businesses
Table 129. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. Granules Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Granules Recent Developments
Table 132. Ganesh Company Information
Table 133. Ganesh Description and Major Businesses
Table 134. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 135. Ganesh Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ganesh Recent Developments
Table 137. Chemcon Company Information
Table 138. Chemcon Description and Major Businesses
Table 139. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 140. Chemcon Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Chemcon Recent Developments
Table 142. BASF Company Information
Table 143. BASF Description and Major Businesses
Table 144. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 145. BASF Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. BASF Recent Developments
Table 147. Porton Company Information
Table 148. Porton Description and Major Businesses
Table 149. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 150. Porton Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Porton Recent Developments
Table 152. Lianhetech Company Information
Table 153. Lianhetech Description and Major Businesses
Table 154. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 155. Lianhetech Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Lianhetech Recent Developments
Table 157. ABA Chem Company Information
Table 158. ABA Chem Description and Major Businesses
Table 159. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 160. ABA Chem Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. ABA Chem Recent Developments
Table 162. Tianma Company Information
Table 163. Tianma Description and Major Businesses
Table 164. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 165. Tianma Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Tianma Recent Developments
Table 167. Jiujiujiu Company Information
Table 168. Jiujiujiu Description and Major Businesses
Table 169. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 170. Jiujiujiu Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Jiujiujiu Recent Developments
Table 172. Alpha Company Information
Table 173. Alpha Description and Major Businesses
Table 174. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 175. Alpha Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Alpha Recent Developments
Table 177. Jiuzhou Company Information
Table 178. Jiuzhou Description and Major Businesses
Table 179. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 180. Jiuzhou Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Jiuzhou Recent Developments
Table 182. Yongtai Company Information
Table 183. Yongtai Description and Major Businesses
Table 184. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 185. Yongtai Pharmaceutical Intermediates Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Yongtai Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Pharmaceutical Intermediates Distributors List
Table 190. Pharmaceutical Intermediates Customers List
Table 191. Pharmaceutical Intermediates Market Trends
Table 192. Pharmaceutical Intermediates Market Drivers
Table 193. Pharmaceutical Intermediates Market Challenges
Table 194. Pharmaceutical Intermediates Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Pharmaceutical Intermediates Market Share by Type in 2023 & 2030
Figure 4. GMP Product Picture
Figure 5. Non-GMP Product Picture
Figure 6. Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Pharmaceutical Intermediates Market Share by Application in 2023 & 2030
Figure 8. Antibiotics
Figure 9. Antipyretic Analgesics
Figure 10. Vitamins
Figure 11. Others
Figure 12. Pharmaceutical Intermediates Report Years Considered
Figure 13. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pharmaceutical Intermediates Revenue 2019-2030 (US$ Million)
Figure 15. Global Pharmaceutical Intermediates Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Pharmaceutical Intermediates Revenue Market Share by Region (2019-2030)
Figure 17. Global Pharmaceutical Intermediates Sales 2019-2030 ((K MT)
Figure 18. Global Pharmaceutical Intermediates Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Pharmaceutical Intermediates Sales YoY (2019-2030) & (K MT)
Figure 20. US & Canada Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Pharmaceutical Intermediates Sales YoY (2019-2030) & (K MT)
Figure 22. Europe Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Pharmaceutical Intermediates Sales YoY (2019-2030) & (K MT)
Figure 24. China Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Pharmaceutical Intermediates Sales YoY (2019-2030) & (K MT)
Figure 26. Asia (excluding China) Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales YoY (2019-2030) & (K MT)
Figure 28. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Pharmaceutical Intermediates Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Pharmaceutical Intermediates in the World: Market Share by Pharmaceutical Intermediates Revenue in 2023
Figure 31. Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
Figure 33. Global Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 34. Global Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
Figure 35. Global Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Pharmaceutical Intermediates Revenue Share by Country (2019-2030)
Figure 41. US & Canada Pharmaceutical Intermediates Sales Share by Country (2019-2030)
Figure 42. U.S. Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
Figure 45. Europe Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 46. Europe Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
Figure 47. Europe Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 48. Europe Pharmaceutical Intermediates Revenue Share by Country (2019-2030)
Figure 49. Europe Pharmaceutical Intermediates Sales Share by Country (2019-2030)
Figure 50. Germany Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 51. France Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 55. China Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
Figure 56. China Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 57. China Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
Figure 58. China Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 59. Asia Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
Figure 60. Asia Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 61. Asia Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
Figure 62. Asia Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 63. Asia Pharmaceutical Intermediates Revenue Share by Region (2019-2030)
Figure 64. Asia Pharmaceutical Intermediates Sales Share by Region (2019-2030)
Figure 65. Japan Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 69. India Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Pharmaceutical Intermediates Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Pharmaceutical Intermediates Sales Share by Country (2019-2030)
Figure 76. Brazil Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Pharmaceutical Intermediates Revenue (2019-2030) & (US$ Million)
Figure 81. Pharmaceutical Intermediates Value Chain
Figure 82. Pharmaceutical Intermediates Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Intermediates market?
The top companies in the global Pharmaceutical Intermediates market are Lonza、Catalent、Patheon.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Pharmaceutical Intermediates market size from 2024 to 2030?
What was the global market size of Pharmaceutical Intermediates in 2024?
What was the global market size of Pharmaceutical Intermediates in 2030?
Related Reports
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-16
Pages: 173
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 143
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 178
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 108
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 172
USD 4900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 147
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 136
USD 2900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-16
Pages: 173
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 143
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 178
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 108
USD 4250.00 (Single User License)Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 172
USD 4900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 147
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 136
USD 2900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report